(CercleFinance.com) – The week begins in depression on European markets (-1.5% in London, -2.1% in Frankfurt, -2% in Paris) against a background of concerns about the budget issue in the United States and the regulatory policy of the Chinese authorities.
‘The United States Congress will be monitored with the vote on the increase in the country’s debt limit’, points out IG France, recalling that Janet Yellen warned that in the event of a default on the debt quickly, the country could be in default.
‘China will also be watched with fears that the party will continue its regulation of large companies (…), while the second Chinese real estate developer Evergrande faces more and more difficulties with its debt’, adds- he does.
No data is expected on Monday, but the next few days will see the release of real estate sector figures, Conference Board leading indicators, the preliminary PMI index and especially the Fed’s monetary policy decision in the United States.
On this side of the Atlantic, will be published this week, in addition to preliminary PMIs, business climate indices in France and Germany and a new estimate of Spanish growth in the second quarter.
In the news of values, operators should also take note of several notable quarterly publications in the United States, such as those of FedEx, General Mills, Nike or Accenture.
Meanwhile, AstraZeneca is up nearly 3% in London after the publication of positive study results on Enhertu in breast cancer, the treatment having notably more than tripled progression-free survival of the disease.
In addition, it should be noted that Airbus makes its entry into the new flagship index of Frankfurt, the DAX40, from this day, and concomitantly leaves the MDAX of which the aircraft manufacturer was part since its birth in 2000.
– .
